Spruce biosciences appoints percival barretto-ko to board of directors

South san francisco, calif.--(business wire)---- $sprb--spruce biosciences, inc. (nasdaq: sprb), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced the appointment of percival barretto-ko to the company's board of directors. concurrently, dina chaya, ph.d., has stepped down from the board of directors. “on behalf of spruce, i am pleased to welcome percival barretto-ko to our boa.
SPRB Ratings Summary
SPRB Quant Ranking